Stay updated on FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.

Latest updates to the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded a note that PubMed publications are automatically filled in from PubMed and updated the page revision to v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedRemoved the government funding/operating status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check49 days agoChange DetectedNo significant changes detected on the study details page; the core information and layout remain as previously shown. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check78 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.SummaryDifference3%

- Check85 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0. No substantive content changes detected.SummaryDifference0.1%

- Check100 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; a Back to Top link was removed (minor UI change).SummaryDifference0.2%

Stay in the know with updates to FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.